Physician profile
Daniel Caldwell Austin
NPI 1730599648
$2,075.27
in general payments reported to CMS, 2019-2025
6 companies · $829 in 2025
The $829 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $70.38 · 2021: $74.95 · 2022: $584 · 2023: $66.27 · 2024: $451 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600 · Education: $546 · Travel and Lodging: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.91 |
| Education | $546.06 |
| Travel and Lodging | $200.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,687.58 | 2021-2025 | Comprehensive Shoulder System, Tapestry, Comprehensive |
| Stryker Corporation | $134.03 | 2020-2023 | Variax |
| Powerlink Ai, INC. | $123.94 | 2025 | |
| Kairos Surgical INC | $70.82 | 2024 | |
| Davol INC. | $35.76 | 2023 | |
| Medacta USA, INC. | $23.14 | 2025 | Mecta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.